Can tramadol be used safely during pregnancy, and what are the recommended dosing limits and monitoring guidelines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tramadol Should Be Avoided During Pregnancy

Tramadol should not be used during pregnancy due to significant safety concerns, including FDA warnings against use prior to or during labor, evidence of placental transfer, and risks of neonatal withdrawal syndrome. 1

Key Safety Concerns

FDA Drug Label Warnings

The FDA explicitly states that tramadol hydrochloride should not be used in pregnant women prior to or during labor unless potential benefits outweigh the risks 1. Critical concerns include:

  • Placental transfer: Tramadol crosses the placenta with a mean umbilical vein to maternal vein ratio of 0.83 1
  • Chronic use risks: Physical dependence and post-partum withdrawal symptoms in newborns 1
  • Post-marketing reports: Neonatal seizures, neonatal withdrawal syndrome, fetal death, and stillbirth 1
  • Unknown long-term effects: The impact on later growth, development, and functional maturation of the child remains unstudied 1

Clinical Evidence on Pregnancy Outcomes

The research evidence presents mixed findings but raises important concerns:

Spontaneous abortion risk: One French database study found a nearly 2-fold increased risk of spontaneous pregnancy termination with tramadol exposure (adjusted HR 1.86 compared to unexposed women, 2.23 compared to codeine-exposed women) 2. However, a Danish cohort study found no increased risk (HR 1.06,95% CI 0.99-1.14) 3.

Congenital malformations: The evidence is conflicting:

  • A Swedish registry study of 1,751 exposed pregnancies found a modestly increased risk of relatively severe malformations (adjusted OR 1.33,95% CI 1.05-1.70), with specific increases in cardiovascular defects (OR 1.56) and clubfoot/pes equinovarus (OR 3.63) 4
  • The Danish study found no increased risk (RR 1.04,95% CI 0.87-1.24) 3
  • The French study similarly found no association (adjusted OR 1.24,95% CI 0.86-1.79) 2

Neonatal Withdrawal Syndrome

Neonatal abstinence syndrome is a well-documented risk with chronic tramadol use during pregnancy. Case reports demonstrate withdrawal symptoms developing 36 hours after delivery, requiring treatment with phenobarbital for up to 9 days 5. This represents a serious clinical concern requiring neonatal monitoring and potential pharmacologic intervention.

Clinical Recommendations

During Pregnancy

Avoid tramadol entirely during pregnancy. If a pregnant woman presents already taking tramadol:

  1. Do not initiate tramadol for new pain complaints during pregnancy
  2. For chronic pain patients on tramadol: Consider transitioning to safer alternatives under specialist guidance, though abrupt discontinuation should be avoided due to withdrawal risks
  3. If tramadol use is unavoidable: Use the lowest effective dose for the shortest duration possible, with full informed consent about risks

Alternative Pain Management

Prioritize non-opioid analgesics when possible:

  • Acetaminophen remains the first-line analgesic during pregnancy (though recent evidence suggests using only when needed at lowest effective doses) 6
  • NSAIDs may be considered in second trimester only (avoid in first and third trimesters)
  • For severe pain requiring opioids: Morphine is preferred over tramadol if strong analgesia is required 7

Labor and Delivery

Tramadol is contraindicated for labor analgesia 1. For opioid-dependent women requiring pain management during labor, the 2019 joint SMFM/ACOG/ASAM guidelines recommend:

  • Neuraxial analgesia (epidural or combined spinal-epidural) as the preferred modality 8
  • Continuation of baseline medication-assisted treatment (methadone or buprenorphine) throughout labor 8
  • Avoidance of opioid agonist/antagonists that can precipitate withdrawal 8

Breastfeeding Considerations

Tramadol should be used with extreme caution during breastfeeding, if at all. The 2020 Association of Anaesthetists guideline notes:

  • Tramadol and its active metabolite O-desmethyltramadol are excreted in breast milk 7
  • Case reports document respiratory depression and death in breastfed infants 7
  • FDA issued a 2017 warning against tramadol use while breastfeeding 7
  • If used, restrict to inpatient settings only with limited total dose and close infant monitoring for sedation, respiratory depression, and decreased alertness 7

Common Pitfalls to Avoid

  1. Assuming tramadol is "safer" than traditional opioids: Despite being a weak opioid, tramadol carries specific pregnancy risks including placental transfer and neonatal withdrawal
  2. Failing to plan for neonatal monitoring: Any infant exposed to chronic tramadol requires at least 3 days of hospital observation for withdrawal symptoms 5
  3. Abrupt discontinuation: In women already dependent on tramadol, sudden cessation can cause maternal withdrawal that may harm both mother and fetus
  4. Overlooking the indication bias: Women requiring tramadol during pregnancy often have underlying conditions (chronic pain, other comorbidities) that themselves may contribute to adverse outcomes

The weight of evidence, particularly the FDA drug label warnings and documented cases of neonatal harm, supports avoiding tramadol during pregnancy whenever possible.

Related Questions

Can a woman who is 5 weeks pregnant with severe pain, who has already tried acetaminophen (paracetamol) without relief, take 50 mg of tramadol?
Can a pregnant patient take tramadol (ultram)?
What is the duration of tramadol's serotonergic effect in the bloodstream?
Is low‑dose tramadol (25 mg orally or intravenously every 6–8 hours, not exceeding 200 mg per day) appropriate for postoperative analgesia in a first‑trimester pregnant patient undergoing an appendectomy after acetaminophen and regional techniques have been employed?
Can a 50 mg tramadol tablet be split in half to obtain a 25 mg dose?
Can tadalafil (Cialis) be safely used together with tamsulosin (Flomax), and what precautions regarding dosing and hypotension should be considered?
What is the appropriate immediate evaluation and management for a patient presenting with dysarthria, paresthesia in the upper and lower extremities, and weakness?
What gastrointestinal conditions could be causing a female patient's right lower quadrant pain and constipation that worsen with menses?
In a male patient with bone‑only metastatic castration‑resistant prostate cancer who has received docetaxel, continuous androgen deprivation therapy with orchiectomy, long‑term abiraterone, targeted radiation, a single dose of sipuleucel‑T (Provenge) discontinued due to allergy, and three cycles of Lu‑177‑PSMA‑617 (Pluvicto), and who started the investigational androgen‑receptor ligand‑directed degrader BMS‑986460 (1 mg daily) with an initial PSA rise followed by decline to 13.06 ng/mL and a recent 19 % increase to 15.6 ng/mL, castrate testosterone, stable hematologic parameters, and molecular findings of AR amplification, TP53 rearrangement, and CHEK2 alteration, is he still deriving clinical benefit from BMS‑986460 or is he developing emerging resistance?
How does Entresto (sacubitril/valsartan) affect serum potassium and sodium levels?
What is the best medication for vaginal dryness in a 77-year-old postmenopausal female?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.